Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth
Molecules · 2025
DOI: 10.3390/molecules30153099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jihyeon Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Tumor-Associated Macrophages, Macrophages, Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grants funded by the Ministry of Science and ICT, Republic of Korea, National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) play a critical role in the tumor microenvironment (TME), interacting with cancer cells and other components to promote tumor growth. Given the influence of TAMs on tumor progression and resistance to therapy, regulating the activity of these macrophages is crucial for improving cancer treatment outcomes. TAMs often exhibit immunosuppressive phenotypes (commonly referred to as M2-like macrophages), which suppress immune responses and contribute to drug resistance. Therefore, inhibiting immunosuppressive polarization offers a promising strategy to impede tumor growth. This study revealed retinoic acid receptor gamma (RARγ), a nuclear receptor, as a key regulator of immunosuppressive polarization in THP-1 macrophages. Indeed, the inhibition of RARγ, either by a small molecule or gene silencing, significantly reduced the expression of immunosuppressive macrophage markers. In a three-dimensional tumor spheroid model, immunosuppressive macrophages enhanced the proliferation of HCT116 colorectal cancer cells, which was significantly hindered by RARγ inhibition. These findings suggest that targeting RARγ reprograms immunosuppressive macrophages and mitigates the tumor-promoting effects of TAMs, highlighting RARγ as a promising therapeutic target for developing novel anti-cancer strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.
- New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu 41061, Republic of Korea.
- Department of Innovative Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
- Cell & Matrix Research Institute, Kyungpook National University, Daegu 41566, Republic of Korea.
- Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
ORCID-Profile: Jong-Sup Bae
Förderung
- National Research Foundation of Korea (NRF) grants funded by the Ministry of Science and ICT, Republic of Korea
- National Research Foundation of Korea (NRF)
Zitieren
APA
Park, J., Oh, J., Min, S. H., Yu, J. H., Bae, J. S., & Jeon, H. J. (2025). Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth. Molecules. https://doi.org/10.3390/molecules30153099
Vancouver
Park J, Oh J, Min SH, Yu JH, Bae JS, Jeon HJ. Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth. Molecules. 2025. doi:10.3390/molecules30153099
BibTeX
@article{Park2025,
author = {Park, Jihyeon and Oh, Jisun and Min, Sang-Hyun and Yu, Ji Hoon and Bae, Jong-Sup and Jeon, Hui-Jeon},
title = {Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30153099}
}
EUVIMED